Picking the Wrong Horse? Accentia vs. Biovest

I am getting a lot of emails and comments on yesterday's article about Biovest (BVTI.PK) and Accentia (ABPIQ.PK). Some suggest that I need to do more homework on the bankruptcy proceedings for these two companies, and I couldn’t agree more. As I pointed out in the earlier post, I am uncomfortable trading this without a solid understanding of the plans of reorganization and the status of the bankruptcy proceedings. I’m just not willing to trade a bankruptcy-related stock unless I am convinced that the common will not be canceled or diluted beyond recognition.

So you all are right — every trader in Biovest and Accentia needs to do their homework on the reorganizations. If anyone has a link to the plans of reorganization please post in the comments. Otherwise I’ll try to dig it up from the SEC filings or court filings when I have the chance.

Another reader, Moe, commented that I was “picking the wrong horse” by focusing on Biovest rather than Accentia. To be clear I haven’t picked either for my personal portfolio, but his point is well taken. Both are on my watchlist. Here is a chart of Accentia:

DISCLOSURE: no positions.

Comments

[jimmy Turano:]

YOU CAN INCLUDE THIS TO YOUR ARTICLE:
"PICKING THE WRONG HORSE"
MRNA VS BDSI
MRNA VS AMLN
MRNA VS ADLS
But one thing to ponder, some people seem to always pick the wrong horse in general, even if you make them aware of a good quality company with tremendous potential, they still like the odds of an upset if you will.

Jun 08 01:54 PM

[svygear:]

Great article... but I think I have a solid pharma play in Access Pharmaceuticals. Press Release Here:
pitch.pe/14217

Ticker: ACCP

Jun 08 03:55 PM

[Ellito:]

That horse you pick (BVTI) could be towing a wagon
full of gold. Think about it.

Jun 15 05:49 AM

[LABPADRE:]

I've been holding on to ABPIQ.PK for quite some time now. We should see some results after the drug hits the public in the U.K.

Jul 23 06:52 PM